HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Kondoh Selected Research

Anaplastic Lymphoma Kinase

12/2014Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer.
11/2014Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Kondoh Research Topics

Disease

17Neoplasms (Cancer)
01/2023 - 03/2009
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2013
3Breast Neoplasms (Breast Cancer)
09/2022 - 05/2011
3Brain Neoplasms (Brain Tumor)
01/2022 - 11/2014
3Neoplasm Metastasis (Metastasis)
01/2022 - 11/2014
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2022 - 06/2022
2Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2022 - 06/2022
1Adenocarcinoma of Lung
01/2023
1Lymphatic Metastasis
01/2022
1Pneumonia (Pneumonitis)
12/2021
1Stomach Neoplasms (Stomach Cancer)
02/2012
1Endometrial Neoplasms (Endometrial Cancer)
05/2011
1Hypersensitivity (Allergy)
11/2002

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
01/2023 - 01/2021
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2020
3Bevacizumab (Avastin)FDA Link
09/2022 - 01/2020
3AntibodiesIBA
02/2022 - 01/2021
3LigandsIBA
02/2022 - 01/2021
3alectinibIBA
12/2014 - 09/2014
3Proteins (Proteins, Gene)FDA Link
10/2013 - 05/2009
2B7-H1 AntigenIBA
01/2023 - 01/2022
2obinutuzumabIBA
06/2022 - 06/2022
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2020
2Anaplastic Lymphoma KinaseIBA
12/2014 - 11/2014
2CrizotinibIBA
11/2014 - 09/2014
2Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2013 - 02/2012
2CH5164840IBA
10/2013 - 02/2012
2Trastuzumab (Herceptin)FDA Link
02/2012 - 05/2011
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2011 - 03/2011
2CH 5132799IBA
05/2011 - 03/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1palbociclibIBA
09/2022
1Growth Factor ReceptorsIBA
09/2022
1Hormones (Hormone)IBA
09/2022
1Bendamustine HydrochlorideFDA Link
06/2022
1Prednisolone (Predate)FDA LinkGeneric
06/2022
1ChemokinesIBA
02/2022
1atezolizumabIBA
12/2021
1Angiogenesis InhibitorsIBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2013
1Lapatinib (GW572016)FDA Link
02/2012
1Molecular Chaperones (Chaperone, Molecular)IBA
02/2012
1human ERBB2 proteinIBA
02/2012
1Mechanistic Target of Rapamycin Complex 1IBA
05/2011
1LipidsIBA
03/2011
1Phosphotransferases (Kinase)IBA
03/2011
1NocodazoleIBA
05/2009
1EnzymesIBA
03/2009
1Amino AcidsFDA Link
11/2002

Therapy/Procedure

6Therapeutics
01/2023 - 02/2012
2Aftercare (After-Treatment)
09/2022 - 06/2022
2Drug Therapy (Chemotherapy)
09/2022 - 12/2021
2Retreatment
06/2022 - 06/2022
2Immunotherapy
12/2021 - 01/2021
1Oral Administration
02/2012